Learn the Facts About Marijuana
NORML supports the adoption of a legally controlled market for marijuana, where consumers can buy marijuana for personal use from a safe legal source. This policy, generally known as legalization has been adopted (either in part or in full) in a number of US jurisdictions: Alaska, California, Colorado, District of Columbia, Illinois, Maine, Massachusetts, Michigan, Nevada,
Oregon, Vermont, and Washington. At present, Washington state does not permit personal home cultivation, and Vermont and the District of Columbia do not permit retail sales.
Modern research suggests that cannabis is a valuable aid in the treatment of a wide range of clinical applications. These include pain relief — particularly of neuropathic pain (pain from nerve damage) — nausea, spasticity, and movement disorders. Marijuana is also a powerful appetite stimulant, specifically for patients suffering from HIV, the AIDS wasting syndrome, or dementia, among other disorders.
More than 60 U.S. and international health organizations support granting patients immediate legal access to medicinal marijuana under a physician’s supervision and the majority of US states now regulate its retail access.
Cannabis policy ought to be evidence based. That is why NORML has prepared the following fact sheets highlighting the relevant peer-reviewed science pertaining to the health and societal impacts of cannabis use, enforcement, and regulation.
- Marijuana Regulation: Impact on Health, Safety, Economy
- Marijuana Regulation and Teen Use Rates
- Relationship Between Marijuana and Opioids
- Marijuana Regulation and Crime Rates
- Societal Impacts of Cannabis Dispensaries/Retailers
- Marijuana Legalization and Impact on the Workplace
- Marijuana and Veterans Issues
- Racial Disparity In Marijuana Arrests
- Marijuana and Psychomotor Performance
- Marijuana Exposure and Cognitive Performance
- Cannabis Exposure and Lung Health
- Maternal Marijuana Use and Childhood Outcomes
- Marijuana and the ‘Gateway Theory’
- Core Attributes of Adult Access Regulations
- Core Attributes of a Patient-Centric, Medical Cannabis Regulatory Program
- FAQs About Cannabidiol (CBD)
For over 40 years, NORML has served as a clearinghouse for marijuana-related information that includes health reports, the latest national and state polls, written testimony, and arrest data. To date, are tens of thousands of published studies or reviews in the scientific literature referencing the cannabis plant and its cannabinoids, nearly half of which were published within ten years.